The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Localization of Diacylglycerol Lipase-α around Postsynaptic Spine Suggests Close Proximity between Production Site of an Endocannabinoid, 2-Arachidonoyl-glycerol, and Presynaptic Cannabinoid CB1 Receptor
Open accessAbstract
2-Arachidonoyl-glycerol (2-AG) is an endocannabinoid that is released from postsynaptic neurons, acts retrogradely on presynaptic cannabinoid receptor CB1, and induces short- and long-term suppression of transmitter release. To understand the mechanisms of the 2-AG-mediated retrograde modulation, we investigated subcellular localization of a major 2-AG biosynthetic enzyme, diacylglycerol lipase-α (DAGLα), by using immunofluorescence and immunoelectron microscopy in the mouse brain. In the cerebellum, DAGLα was predominantly expressed in Purkinje cells. DAGLα was detected on the dendritic surface and occasionally on the somatic surface, with a distal-to-proximal gradient from spiny branchlets toward somata. DAGLα was highly concentrated at the base of spine neck and also accumulated with much lower density on somatodendritic membrane around the spine neck. However, DAGLα was excluded from the main body of spine neck and head. In hippocampal pyramidal cells, DAGLα was also accumulated in spines. In contrast to the distribution in Purkinje cells, DAGLα was distributed in the spine head, neck, or both, whereas somatodendritic membrane was labeled very weakly. These results indicate that DAGLα is essentially targeted to postsynaptic spines in cerebellar and hippocampal neurons, but its fine distribution within and around spines is differently regulated between the two neurons. The preferential spine targeting should enable efficient 2-AG production on excitatory synaptic activity and its swift retrograde modulation onto nearby presynaptic terminals expressing CB1. Furthermore, different fine localization within and around spines suggests that the distance between postsynaptic 2-AG production site and presynaptic CB1 is differentially controlled depending on neuron types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 2×
“2-Arachidonoyl-glycerol (2-AG) is one of the two major endocannabinoids (Devane et al., 1992; Mechoulam et al., 1995; Sugiura et al., 1995) and is synthesized on demand from DAG by sn-1-specific diacylglycerol lipase (DAGL) (Stella et al.”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · cited 3×
“…retrograde suppression (ERS) was found originally in the cerebellum (Kreitzer and Regehr, 2001a; Maejima et al., 2001) and hippocampus (Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001) and later in other brain regions (Alger, 2002; Wilson and Nicoll, 2002; Piomelli, 2003).”
BackgroundImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 2×
“Because the 2-AG-degrading enzyme monoglyceride lipase (MGL) is selectively localized in axons and terminals (Dinh et al., 2002; Gulyas et al., 2004), this preferential distribution would enable 2-AG to activate CB1 without passing through MGL-rich axoplasm and thereby contributes to the increasing of efficiency for e…”
BackgroundEndocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 5×
“…mice have provided evidence that CB1 is the major presynaptic cannabinoid receptor at inhibitory and excitatory synapses in various brain regions (Katona et al., 1999, 2001; Farquhar-Smith et al., 2000; Hajos et al., 2000, 2001; Wilson and Received Jan. 6, 2006; revised March 18, 2006; accepted…”
BackgroundInfluentialBisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Altman, J. (1972) · Journal of Comparative Neurology · doi:10.1002/cne.901450402 · Cited by 996 · cited 2×
“To test this possibility, we applied triple immunolabeling to the cerebellum at P10, when climbing fibers predominantly innervate somatic spines before translocation to dendrites (Altman, 1972; Chedotal and Sotelo, 1992).”
MethodBaude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Luján, R., Nusser, Z., Roberts, J. D. B., Shigemoto, R., & Somogyi, P. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01611.x · Cited by 861
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
Self-citationKatona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668 · cited 1×
“…mice have provided evidence that CB1 is the major presynaptic cannabinoid receptor at inhibitory and excitatory synapses in various brain regions (Katona et al., 1999, 2001; Farquhar-Smith et al., 2000; Hajos et al., 2000, 2001; Wilson and Received Jan. 6, 2006; revised March 18, 2006; accepted…”
BackgroundMailleux, P., & Vanderhaeghen, J.-J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 664
Interneuron Diversity series: Rhythm and mood in perisomatic inhibition
Freund, T. F. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00227-3 · Cited by 641
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561 · cited 3×
“Spine is the major site of 2-AG synthesis in hippocampal pyramidal cell CB1 and 2-AG mediates ERS in the hippocampus as well (Hajos et al., 2000; Varma et al., 2001; Wilson and Nicoll, 2001; Hashimotodani et al., 2005).”
BackgroundMaejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 555
Self-citationCannabinoids inhibit hippocampal GABAergic transmission and network oscillations
Hájos, N., Katona, I., Naiem, S. S., Mackie, K., Ledent, C., Mody, I., & Freund, T. F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00217.x · Cited by 533
Kawamura, Y., Fukaya, M., Maejima, T., Yoshida, T., Miura, E., Watanabe, M., Ohno-Shosaku, T., & Kano, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4872-05.2006 · Cited by 489
Self-citationHájos, N., Ledent, C., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 419
Nusser, Z., Mulvihill, E., Streit, P., & Somogyi, P. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90421-9 · Cited by 415
Impaired synapse elimination during cerebellar development in PKCγ mutant mice
Kano, M., Hashimoto, K., Chen, C., Abeliovich, A., Aiba, A., Kurihara, H., Watanabe, M., Inoue, Y., & Tonegawa, S. (1995) · Cell · doi:10.1016/0092-8674(95)90147-7 · Cited by 409
Self-citationMetabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
Varma, N., Carlson, G. C., Ledent, C., & Alger, B. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0003.2001 · Cited by 406
Luján, R., Roberts, J. D. B., Shigemoto, R., Ohishi, H., & Somogyi, P. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00051-3 · Cited by 395
Tsou, K., Mackie, K., Sañudo-Peña, M. C., & Walker, J. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00086-x · Cited by 343
Bodor, Á. L., Katona, I., Nyíri, G., Mackie, K., Ledent, C., Hájos, N., & Freund, T. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0442-05.2005 · Cited by 325
Fritschy, J.-M., Weinmann, O., Wenzel, A., & Benke, D. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980112)390:2<194::aid-cne3>3.0.co;2-x · Cited by 323
Kim, J., Isokawa, M., Ledent, C., & Alger, B. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10182.2002 · Cited by 318
Hashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H.-S., & Kano, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.004 · Cited by 315
Self-citationMiyazaki, T., Fukaya, M., Shimizu, H., & Watanabe, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02698.x · Cited by 313
Self-citationPersistent Multiple Climbing Fiber Innervationof Cerebellar Purkinje Cellsin Mice Lacking mGluR1
Kano, M., Hashimoto, K., Kurihara, H., Watanabe, M., Inoue, Y., Aiba, A., & Tonegawa, S. (1997) · Neuron · doi:10.1016/s0896-6273(01)80047-7 · Cited by 305
Self-citationOhno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zimmer, A., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03864.2002 · Cited by 301
Self-citationWatanabe, M., Fukaya, M., Sakimura, K., Manabe, T., Mishina, M., & Inoue, Y. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00063.x · Cited by 293
Self-citationBaude, A., Nusser, Z., Molnar, E., McIlhinney, R. A. J., & Somogyi, P. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00350-r · Cited by 290
Cannabinoid CB1 Receptor Expression in Rat Spinal Cord
Farquhar-Smith, W. P., Egertová, M., Bradbury, E. J., McMahon, S. B., Rice, A. S. C., & Elphick, M. R. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0844 · Cited by 268
Offermanns, S., Hashimoto, K., Watanabe, M., Sun, W., Kurihara, H., Thompson, R. F., Inoue, Y., Kano, M., & Simon, M. I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14089 · Cited by 265
Self-citationEndocannabinoids Control the Induction of Cerebellar LTD
Safo, P. K., & Regehr, W. G. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.020 · Cited by 263
Melis, M., Perra, S., Muntoni, A. L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G. L., & Pistis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3502-04.2004 · Cited by 253
Köfalvi, A., Rodrigues, R. J., Ledent, C., Mackie, K., Vizi, E. S., Cunha, R. A., & Sperlágh, B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4232-04.2005 · Cited by 242
Fukudome, Y., Ohno‐Shosaku, T., Matsui, M., Omori, Y., Fukaya, M., Tsubokawa, H., Taketo, M. M., Watanabe, M., Manabe, T., & Kano, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03384.x · Cited by 238
Self-citationBrown, S. P., Brenowitz, S. D., & Regehr, W. G. (2003) · Nature Neuroscience · doi:10.1038/nn1126 · Cited by 234
Maejima, T., Oka, S., Hashimotodani, Y., Ohno-Shosaku, T., Aiba, A., Wu, D., Waku, K., Sugiura, T., & Kano, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0945-05.2005 · Cited by 229
Self-citationYamasaki, M., Yamada, K., Furuya, S., Mitoma, J., Hirabayashi, Y., & Watanabe, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07691.2001 · Cited by 220
Self-citationDiana, M. A., Levenes, C., Mackie, K., & Marty, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00200.2002 · Cited by 199
Kano, M., Hashimoto, K., Watanabe, M., Kurihara, H., Offermanns, S., Jiang, H., Wu, Y., Jun, K., Shin, H.-S., Inoue, Y., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15724 · Cited by 193
Self-citationYamada, K., Fukaya, M., Shibata, T., Kurihara, H., Tanaka, K., Inoue, Y., & Watanabe, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000228)418:1<106::aid-cne8>3.0.co;2-n · Cited by 186
Self-citationYoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01690.2002 · Cited by 179
Self-citationIchikawa, R., Miyazaki, T., Kano, M., Hashikawa, T., Tatsumi, H., Sakimura, K., Mishina, M., Inoue, Y., & Watanabe, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08487.2002 · Cited by 176
Self-citationNakamura, M., Sato, K., Fukaya, M., Araishi, K., Aiba, A., Kano, M., & Watanabe, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03768.x · Cited by 168
Self-citationOhno‐Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., Manabe, T., & Kano, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02732.x · Cited by 166
Self-citationFukaya, M., & Watanabe, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001030)426:4<572::aid-cne6>3.0.co;2-9 · Cited by 166
Self-citationAssociative Short-Term Synaptic Plasticity Mediated by Endocannabinoids
Brenowitz, S. D., & Regehr, W. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.045 · Cited by 158
Watanabe, M., Nakamura, M., Sato, K., Kano, M., Simon, M. I., & Inoue, Y. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00213.x · Cited by 143
Self-citationOrganization of Glutamate Receptors at the Synapse
Ottersen, O. P., & Landsend, A. S. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01640.x · Cited by 138
Galante, M., & Diana, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0403-04.2004 · Cited by 126
Tanaka, J., Nakagawa, S., Kushiya, E., Yamasaki, M., Fukaya, M., Iwanaga, T., Simon, M. I., Sakimura, K., Kano, M., & Watanabe, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00959.x · Cited by 124
Self-citationEarly Development of Olivocerebellar Projections in the Fetal Rat Using CGRP Immunocytochemistry
Chédotal, A., & Sotelo, C. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00142.x · Cited by 119
Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells
Brenowitz, S. D., & Regehr, W. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06373.2003 · Cited by 116
Miura, E., Fukaya, M., Sato, T., Sugihara, K., Asano, M., Yoshioka, K., & Watanabe, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03835.x · Cited by 98
Self-citation
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Self-citationAn Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
Metadata
- Authors
- Yoshida, T., Fukaya, M., Uchigashima, M., Miura, E., Kamiya, H., Kano, M., & Watanabe, M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-05-03
- Volume
- 26
- Issue
- 18
- Pages
- 4740-4751
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2055705346
- Cited by
- 327
- References
- 68
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.